Status:
COMPLETED
Port Protectors for Prevention of CLABSIs in Respiratory Semi-intensive Care Unit
Lead Sponsor:
Catholic University of the Sacred Heart
Conditions:
Central Line-associated Bloodstream Infection (CLABSI)
Eligibility:
All Genders
Phase:
NA
Brief Summary
Central Line-Associated BloodStream Infections (CLABSIs) are responsible for many deaths in the United States annually. Several collaboratives have demonstrated the preventability of these infections...
Detailed Description
The study enrolled patients admitted to RICU and it lasted 18 months. Patients were enrolled when a CVC: 1) was placed during hospitalization in RICU; 2) had already been placed at admittance and pati...
Eligibility Criteria
Inclusion
- CVC placed during hospitalization in RICU;
- CVC already placed at admittance without signs of systemic inflammatory response syndrome (SIRS) during first 48h from admission to RICU;
- CVC already placed at admittance without evidence of microbiologic contamination of blood cultures;
- written informed consent.
Exclusion
- CVC placed during hospitalization in other Hospital;
- CVC placed during hospitalization in other Unit with signs of systemic inflammatory response syndrome (SIRS) during first 48h from admission to RICU and / or evidence of microbiologic contamination of blood cultures.
Key Trial Info
Start Date :
April 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2014
Estimated Enrollment :
132 Patients enrolled
Trial Details
Trial ID
NCT03486093
Start Date
April 1 2013
End Date
September 1 2014
Last Update
April 3 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.